FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Pivot

  • Home
  •  | 
  • Tag Archives: "Pivot"

Pivot Pharma Signs Letter of Intent with Pharmascience Inc.

Pivot Pharma Signs Letter of Intent with Pharmascience Inc.
Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has signed a Letter of Intent, dated February 26th, 2019, with Pharmascience Inc. ("Pharmascience") whereby Pharmascience will conduct analytical testing, collaborate on development and research of new medicinal products containing cannabis or cannabis derivatives and drugs containing cannabis and/or cannabis derivatives, provide regulatory support necessary to attain Marketing Authorization, and marketing and distribution of finished pharmaceutical dosage forms. Further terms and details will be provided upon the execution of the Definitive Agreement.
Read more

Pivot Naturals LLC Awarded Temporary License to Manufacture Adult and Medicinal Use Cannabis from the California Department of Public Health

Pivot Naturals LLC Awarded Temporary License to Manufacture Adult and Medicinal Use Cannabis from the California Department of Public Health
Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot") is pleased to announce that it has received a Temporary License from the California Department of Public Health to manufacture adult and medicinal use cannabis-infused products in its Costa Mesa, California facility. Receipt of this license brings Pivot one step closer to production, generating revenue, and bringing its brands to the California ingestible and edible cannabis market.
Read more

Pivot Signs Letter of Intent With Pharmaflorx For Supply Of Cannabis Oils And Isolates Minimum of 1,000 KG/Annually For Use In Pivot’s Product Pipeline

Pivot Signs Letter of Intent With Pharmaflorx For Supply Of Cannabis Oils And Isolates Minimum of 1,000 KG/Annually For Use In Pivot’s Product Pipeline
Pivot will purchase a minimum of 1,000 kg/year of cannabis oils or isolates from PFX for manufacturing of Pivot's patented portfolio of biocannabis products. Upon receipt of appropriate licenses in Canada, Pivot intends to supply both the Canadian and European Union markets with its suite of patented, formulated and bioavailable products, including CBD and/or THC-based creams, lotions, capsules, tablets, bulk powder, infused beverages and pet supplements, where regulations permit.
Read more

Pivot Signs Exclusive Co-Marketing And Distribution Agreement with Swiss-based S.T.U. GmbH, Establishes Large Retail and Online Sales Channels In The European Union

Pivot Signs Exclusive Co-Marketing And Distribution Agreement with Swiss-based S.T.U. GmbH, Establishes Large Retail and Online Sales Channels In The European Union
VANCOUVER, Aug. 2, 2018 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has entered into a Definitive Co-marketing and Distribution Agreement ("the Agreement") with S.T.U. GmbH ("S.T.U."), a Switzerland-based company that manufactures and markets "Hemplix™" brand CBD oils. Under the terms of the Agreement, S.T.U. will market and sell Pivot's proprietary cannabinoid-derived products online and in retail outlets in the U.K., Switzerland, Germany, Austria and Italy (where regulations permit). In addition, Pivot will distribute the Hemplix™ product line in Canada, Latin America and the United States, where regulations permit and upon receipt of necessary licenses from regulatory authorities.
Read more